Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Purdue Pharma founded RADARS in 2001. Photo: Drew Angerer/Getty Images
A small yet influential group called Researched Abuse, Diversion and Addiction-Related Surveillance, or RADARS, monitors how opioids are misused across the nation. It also accepts money from the companies that make those opioids.
Why it matters: Health care experts view RADARS as a credible, independent resource, but its ties to the pharmaceutical industry raise questions about how the group operates.
How it works: RADARS tracks opioid misuse and abuse by collecting phone call information from poison control centers and patient survey data from addiction treatment programs.
- This allows RADARS to know about pills children are accidentally swallowing, or which legal and illicit opioids are driving people to seek rehab.
Details: Purdue Pharma, the maker of OxyContin, founded RADARS in 2001 after concerns of prescription painkiller addictions started to rise.
- But having an opioid company track misuse of its own products gave the perception that the fox was guarding the henhouse, so Purdue sold RADARS to Denver Health, a publicly owned hospital system in Colorado that also houses a poison and drug center.
RADARS still has close connections to the pharmaceutical industry.
- RADARS and its affiliated poison center brought in more than $25 million of revenue last year for Denver Health — most of which is subscription fees, from opioid manufacturers and others, to get access to its data.
- Researchers paid by RADARS have written articles that line up with industry views. For example, a 2015 article in the New England Journal of Medicine said the U.S. was "making progress in combating the abuse of prescription opioid analgesics" even though the overall number of overdose deaths from prescription opioids has remained pretty much the same.
- Richard Dart, the head of RADARS, received more than $112,0000 from Purdue Pharma in 2014 for his consulting work on the company's opioids, and he has received tens of thousands from other opioid manufacturers. (Denver Health disputed those payments.) Purdue Pharma also has paid for Dart's travel to FDA opioid meetings in the past.
- Johnson & Johnson cited RADARS, in opening testimony in its case versus Oklahoma, to show its opioids were not frequently abused.
What they're saying: Dart referred all questions to lawyers at Denver Health. A Denver Health spokesperson submitted written responses, which acknowledged the system had contracts with Purdue and other manufacturers, but did not respond to follow-up questions.
Go deeper: Drug companies have a history of shaping public opinion and research.